pharmaphorum

JUNE 8, 2021

All these factors will support the growth of in-house R&D-driven pharmaceutical companies and bring more innovative drugs to Asian markets.”. There is no doubt that the APAC markets are prioritising increased investment in healthcare, and this is very encouraging,” says Mei. “If Chemotherapy still accounted for 72.6%

Chemotherapy 105

Chemotherapy Pharmaceutical Companies Pharmaceutical Companies Immunization 105

Pharmaceutical Technology

FEBRUARY 27, 2023

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.

Biosimilars 45

Biosimilars Immunization Immunity Hospitals 45

Pharmaceutical Technology

JUNE 5, 2023

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.

Diabetes 40

Diabetes Immunization Immunity Hospitals 40

Pharmaceutical Technology

FEBRUARY 24, 2023

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.

Chemotherapy 40

Chemotherapy Immunization Immunity Hospitals 40

pharmaphorum

NOVEMBER 16, 2022

Wykoff is director of research at Retina Consultants of Texas, chairman of research at Retina Consultants of America, and deputy chair of ophthalmology for the Blanton Eye Institute, Houston Methodist Hospital.

Immunization 105

Immunization Immunity Hospitals Drug Development 105

Pharmaceutical Technology

FEBRUARY 27, 2023

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.

Biosimilars 40

Biosimilars Immunization Immunity Hospitals 40

Pharmaceutical Technology

FEBRUARY 27, 2023

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.

Biosimilars 40

Biosimilars Immunization Immunity Hospitals 40

PharmaShots

MARCH 6, 2023

It is a vital part of gaining a holistic and 360-degree, data-enabled view of a patient population and involves working together with all stakeholders to answer critical questions along the lifecycle of drug development. In fact, AI can bring value to patients at almost every stage of the drug development and treatment process.

Drug Development 40

Drug Development Immunization Immunity Pharmaceutical Companies 40

European Pharmaceutical Review

NOVEMBER 9, 2023

Following her presentation on age-related disease at BioFuture 2023, Executive Vice President of Drug Development for MyMD Pharmaceuticals ® , Jenna Brager, shares with EPR why the company’s next-generation tumour necrosis factor (TNF)-alpha inhibitor has potential in inflammatory and autoimmune disorders.

Drug Development 115

Drug Development Immunization Immunity Pharmaceutical Companies 115

pharmaphorum

DECEMBER 23, 2022

There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel oral therapies as patient-friendly alternatives.

Drug Development 52

Drug Development Immunization Immunity Hospitals 52

Pharmaceutical Technology

FEBRUARY 1, 2023

As paediatric hospital wings are flooded with an unprecedented number of respiratory syncytial virus (RSV) cases , healthcare workers have been overwhelmed by an unusually early peak of the RSV season. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

Vaccines 64

Vaccines Drug Development Pharmaceutical Companies Pharmaceutical Companies 64

pharmaphorum

JANUARY 18, 2022

Cancer Research UK’s Centre for Drug Development, working with the Ludwig Institute for Cancer Research and Vaccitech, has begun a phase I/IIa clinical trial of a new lung cancer vaccine. Vaccitech and the Ludwig Institute are providing the drug while the Centre manages the trial and provides funding.

Immunization 64

Immunization Immunity Vaccines Drug Development 64

European Pharmaceutical Review

DECEMBER 22, 2022

These hurdles prevent intact therapeutic mRNAs from accumulating in the body or intended tissue and often trigger an immune response. Intramuscular injection is the most used administration route for vaccination…However, this method has so far been unable to achieve sterile immunity. evade endolysosomal degradation .

Immunization 116

Immunization Immunity Vaccines Hospitals 116

Pharmaceutical Technology

JUNE 8, 2023

The companies will offer a comprehensive suite of cell therapy services to biotech, pharmaceutical and government entities, and to hospitals. These solutions will help drug developers address the challenges of regulatory compliance, production scalability, quality assurance and cost-effectiveness.

Vaccines 52

Vaccines Drug Development Immunization Immunity 52

Pharmaceutical Technology

FEBRUARY 24, 2023

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.

Vaccines 40

Vaccines Diabetes Immunization Immunity 40

Pharmaceutical Technology

MARCH 2, 2023

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval.

Chemotherapy 40

Chemotherapy Vaccines Diabetes Immunization 40

pharmaphorum

JANUARY 17, 2022

The drug, developed by Incyte and licenced to Lilly, is also used to treat rheumatoid arthritis. It prevents the overstimulation of the immune system and is said to improve survival and reduce the need for ventilation in covid-19 patients, with no observed increase in adverse effects.

Hospitals 116

Hospitals Diabetes Immunization Immunity 116

STAT

MARCH 6, 2023

“I’m slowly running out of options,” said Young, 62, who in November began   receiving   a five-month series of shots at a clinic near her San Francisco home; the vaccine is designed to teach her immune cells to recognize and combat tumors. “People come to this thinking they will be cured.”

Vaccines 246

Vaccines Bioethics Immunization Immunity 246